Abstract
Objective
To induce a mouse model of scleroderma with repeated bleomycin injections for research into human scleroderma at our research laboratory.
Methods
The protocol of Yamamoto et al. was replicated to establish the bleomycin-induced mouse model of scleroderma.
References
1. Belch JJ, Zoma AA, Richards IM, McLaughlin K, Forbes CD, Sturrock RD. Vascular damage and factor-viii-related antigen in the rheumatic diseases. Rheumatol Int. 1987; 7:107–11.
2. Lau CS, McLaren M, Belch JJ. Factor viii von Willebrand factor antigen levels correlate with symptom severity in patients with Raynaud's phenomenon. Brit J Rheumatol. 1991; 30:433–6.
3. Walmsley D, Goodfield MJ. Evidence for an abnormal peripherally mediated vascular response to temperature in Raynaud's phenomenon. Brit J Rheumatol. 1990; 29:181–4.
5. Yamamoto T, Takagawa S, Katayama I, Yamazaki K, Hamazaki Y, Shinkai H, et al. Animal model of sclerotic skin. I: local injections of bleomycin induce sclerotic skin mimicking scleroderma. J Invest Dermatol. 1999; 112:456–62.